Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials.
Milenic, Diane E
Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials. [electronic resource] - mAbs - 550-64 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
1942-0870
10.4161/mabs.2.5.13054 doi
Animals
Antibodies, Monoclonal--chemistry
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--chemistry
Cell Line, Tumor
Clinical Trials as Topic
Colonic Neoplasms--drug therapy
Female
HT29 Cells
Humans
Immunoconjugates--chemistry
Indium Radioisotopes--administration & dosage
Injections, Intraperitoneal
Injections, Intravenous
Isothiocyanates--chemistry
Male
Melanoma--drug therapy
Mice
Mice, Nude
Ovarian Neoplasms--drug therapy
Pentetic Acid--analogs & derivatives
Positron-Emission Tomography
Prostatic Neoplasms--drug therapy
Radionuclide Imaging
Receptor, ErbB-2--antagonists & inhibitors
Tissue Distribution
Trastuzumab
Xenograft Model Antitumor Assays
Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials. [electronic resource] - mAbs - 550-64 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
1942-0870
10.4161/mabs.2.5.13054 doi
Animals
Antibodies, Monoclonal--chemistry
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--chemistry
Cell Line, Tumor
Clinical Trials as Topic
Colonic Neoplasms--drug therapy
Female
HT29 Cells
Humans
Immunoconjugates--chemistry
Indium Radioisotopes--administration & dosage
Injections, Intraperitoneal
Injections, Intravenous
Isothiocyanates--chemistry
Male
Melanoma--drug therapy
Mice
Mice, Nude
Ovarian Neoplasms--drug therapy
Pentetic Acid--analogs & derivatives
Positron-Emission Tomography
Prostatic Neoplasms--drug therapy
Radionuclide Imaging
Receptor, ErbB-2--antagonists & inhibitors
Tissue Distribution
Trastuzumab
Xenograft Model Antitumor Assays